Explore the future of the pharmaceutical industry with this comprehensive report. Delve into key trends via regulatory, clinical, and market analyses. Essential for investors, new entrants, and pharma ...

Now, in its seventh year, the Grass Roots event—organized annually by The Chromatographic Society—continues to offer a unique ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

Several companies are advancing treatments for anal cancer, including Merck (KEYTRUDA), BioMimetix (BMX-001), Novartis (KFA115), and Bicara Therapeutics (BCA101), among others. As immunotherapy ...

Anal cancer is relatively uncommon, accounting for approximately 2.5% of all gastrointestinal cancers. Nonetheless, its ...

Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung cancer treatment after it ...

But some small print indicates that Nintendo's new GameCube controller for the Switch 2 may only, officially, be meant for GameCube use. Spotted in the details of the UK version of the Switch 2 ...

FILSPARI holds strong market potential as the first FDA-approved non-immunosuppressive therapy for IgA nephropathy, a rare kidney disease with significant unmet needs. As more patients and providers ...

The global Generic Pharmaceuticals Market size is projected to be valued at USD 391.5 billion in 2023 and reach USD 682.9 ...

PGIM Jennison Rising Dividend Fund advanced for Q1 2025 and comfortably outperformed the -4.3% return of the S&P 500 Index.

Discover how AI labs are reshaping R&D by integrating machine learning, robotics, and smart data systems to accelerate ...